In addition to anorexia, fat and muscle tissue wasting, psychological distress, lower tolerance to chemotherapy, and a poor quality of life, cachexia causes profound metabolic dysregulation in cancer patients that affects multiple organs. Here, for the first time, we have characterized metabolic changes in the spleen, liver, pancreas, lung, heart and kidney induced by pancreatic cancer xenografts to expand our understanding of the metabolic dysregulation caused by cachexia. These results highlight the systemic changes in metabolism that occur with cancer and with cancer induced cachexia that may lead to the development of early biomarkers as well to metabolic treatment strategies.
This abstract and the presentation materials are available to members only; a login is required.